Alamance Cancer Center — Burlington, North Carolina

Alamance Cancer Center is a clinical research site located in Burlington, North Carolina, United States 27216.

Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.

Alamance Cancer Center has participated in 6 clinical trials.

Therapeutic areas: Breast Cancer, NSCLC, Leukemia.

Sponsors: NSABP Foundation Inc, CTI BioPharma, Wake Forest University Health Sciences.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Burlington

Browse all research sites in North Carolina · View every site in Burlington

• Cone Health Cancer Center at Alamance Regional
• Research Site
• Alamance Cancer Center at Alamance Regional Medical Center
• Alamance Regional Medical Center
• GSK Investigational Site
• Kernodle Clinic
• Kernodle Clinic West
• Pfizer Investigational Site
• Novo Nordisk Investigational Site
• Laboratory Corporation of America
• Kernodle Clin Dpt-Pvt Diagnost

Sponsor Feasibility Report

Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Alamance Cancer Center?

Alamance Cancer Center has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Alamance Cancer Center conducted?

Alamance Cancer Center has 6 clinical trials on record. Their work covers Breast Cancer, NSCLC, Leukemia.

Is Alamance Cancer Center accredited by Crixeo Clinical Trials?

Alamance Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Alamance Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.